Magsil Antacid (lemon Mint) Tablet, Chewable
NDC Package 51467-100-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Identification & Billing

NDC Package Code
51467-100-01
Package Description
4 BLISTER PACK in 1 BOX / 6 TABLET, CHEWABLE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
51467010001

Clinical Specifications

Proprietary Name
Magsil Antacid (lemon Mint)
Non-Proprietary Name
Aluminum Hydroxide Dried Gel, Magnesium Hydroxide, And Simethicone
Substance Name
Aluminum Hydroxide; Dimethicone; Magnesium Hydroxide
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.

Regulatory & Marketing

Labeler Name
Fortune Pharmacal Company Limited
Product Type
Human Otc Drug
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-20-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51467-100-01 identifies a specific commercial package of 4 blister pack in 1 box / 6 tablet, chewable in 1 blister pack of Magsil Antacid (lemon Mint), a human over the counter drug labeled by Fortune Pharmacal Company Limited. This tablet, chewable is formulated for oral use and contains aluminum hydroxide; dimethicone; magnesium hydroxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fortune Pharmacal Company Limited on September 20, 2017. The current certification is valid through December 31, 2026.

How is this Fortune Pharmacal Company Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51467010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
51467-100-01
11-Digit CMS (5-4-2)
51467-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.